Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, and Diabetes and associated disorders.
Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes
Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus
Testing and Visualization of Associations in Three-Way Contingency Tables: A Study of the Gender Gap in Patients with Type 1 Diabetes and Cardiovascular Complications
Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study
Use of DPP4 Inhibitors and GLP-1 Receptor Agonists and Risk of Intestinal Obstruction: Scandinavian Cohort Study
Use of sodium–glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study
Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study
A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes
Recent trends in life expectancy for people with type 1 diabetes in Sweden
Long-Term Prognosis in Patients With Type 1 and 2 Diabetes Mellitus After Coronary Artery Bypass Grafting